Failure of Calcineurin Inhibitor (Tacrolimus) Weaning Randomized Trial in Long-Term Stable Kidney Transplant Recipients

Long-Term Clinical Impact of Adaptation of Initial Tacrolimus Dosing to CYP3A5 Genotype

(2016) N. Pallet et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Belatacept and Long-Term Outcomes in Kidney Transplantation

(2016) Flavio Vincenti et al.   NEW ENGLAND JOURNAL OF MEDICINE

Loss of Pediatric Kidney Grafts During the “High-Risk Age Window”: Insights From Pediatric Liver and Simultaneous Liver-Kidney Recipients

(2015) K. J. Van Arendonk et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Safe Conversion From Tacrolimus to Belatacept in High Immunologic Risk Kidney Transplant Recipients With Allograft Dysfunction

(2015) G. Gupta et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Adverse Outcomes of Tacrolimus Withdrawal in Immune-Quiescent Kidney Transplant Recipients

(2015) D. E. Hricik et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Biomarkers and possible mechanisms of operational tolerance in kidney transplant patients

(2014) Emilie Dugast et al.   IMMUNOLOGICAL REVIEWS

Through a Glass Darkly: Seeking Clarity in Preventing Late Kidney Transplant Failure

(2014) M. D. Stegall et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

15-Year Follow-up of a Multicenter, Randomized, Calcineurin Inhibitor Withdrawal Study in Kidney Transplantation

(2014) Joke I. Roodnat et al.   TRANSPLANTATION

Long-term outcomes after cyclosporine or mycophenolate withdrawal in kidney transplantation - results from an aborted trial

(2013) Anders Åsberg et al.   CLINICAL TRANSPLANTATION

Differing Effects of Rapamycin or Calcineurin Inhibitor on T-Regulatory Cells in Pediatric Liver and Kidney Transplant Recipients

(2012) T. Akimova et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Human leukocyte antigen mismatches associated with increased risk of rejection, graft failure, and death independent of initial immunosuppression in renal transplant recipients

(2012) Wai H. Lim et al.   CLINICAL TRANSPLANTATION

Diagnosis and prevention of chronic kidney allograft loss

(2011) Brian J Nankivell et al.   LANCET

Two Hundred Living Donor Kidney Transplantations Under Alemtuzumab Induction and Tacrolimus Monotherapy: 3-Year Follow-Up

(2008) H. P. Tan et al.   AMERICAN JOURNAL OF TRANSPLANTATION